AKT1 and cancer: Under growth-factor-free conditions, cells inducibly expressing a cancer-derived constitutively active point mutant (E17K) of AKT exhibited increased AKT-dependent CoA synthesis relative to cells expressing wild-type (WT) AKT (Fig. 1f).